HUM5007

HUM5007 has been studied in 1 paper since 2007: 1 trial in people. The newest paper, Apr 5, 2007: “HUM5007, a novel combination of thermogenic compounds, and 3-acetyl-7-oxo-dehydroepiandrosterone: each increases the resting metabolic rate of overweight adults”.

Intervention

1 paper studies it2 findingsUpdated

See all 1 papers on HUM5007

At a glance

The findings reach people, from one lab or study. 1 lab in 1 country.

“RMR increased significantly by 1.4% (21+/-115 kcal/day) and 3.4% (59+/-118 kcal/day) during the 7-Keto and HUM5007 treatment periods, respectively (each compared to placebo, P=.001).”
HUM5007, a novel combination of thermogenic compounds, and 3-acetyl-7-oxo-dehydroepiandrosterone: each increases the resting metabolic rate of overweight adultsThe Journal of nutritional biochemistry2007doi:10.1016/j.jnutbio.2006.11.008

None of its findings points the other way.

Humans: a single group. Cells, worms or flies and mice: nothing yet.
  • 1 lab in 1 country
  • Human trial1

Studies in people

1 study gave HUM5007 to people and measured what changed.

What changedDesignPeopleSource

up: Increases resting metabolic rate+3.4% (59 kcal/day); placebo −3.9% (−75 kcal/day)

no change: Has no effect on serious adverse events

Randomized trial7-day treatment period40 peopleBothmean 38.5 yearsOn a calorie-restricted dietThe Journal of nutritional biochemistry, Apr 5, 2007

What did studies of HUM5007 find?

2

Studies of HUM5007 measured 2 outcomes: serious adverse events and resting metabolic rate.

Serious adverse events

no changein humans1

1 study
  1. HUM5007 showed no clear effect on serious adverse events in humans.

    “HUM5007 and 7-Keto were generally well tolerated and no serious adverse events were reported.”

    Human trial7-day treatment periodn = 40

    HUM5007, a novel combination of thermogenic compounds, and 3-acetyl-7-oxo-dehydroepiandrosterone: each increases the resting metabolic rate of overweight adults

    The Journal of nutritional biochemistry

Resting metabolic rate

upin humans1

1 study
  1. HUM5007 increases resting metabolic rate in humans (on a calorie-restricted diet; compared with placebo) (+3.4% (59 kcal/day); placebo −3.9% (−75 kcal/day)).

    “RMR increased significantly by 1.4% (21+/-115 kcal/day) and 3.4% (59+/-118 kcal/day) during the 7-Keto and HUM5007 treatment periods, respectively (each compared to placebo, P=.001).”

    Human trialon a calorie-restricted diet; compared with placebocombination of 7-keto, calcium citrate, green tea extract, ascorbic acid, chromium nicotinate and cholecalciferol7-day treatment periodn = 40

    HUM5007, a novel combination of thermogenic compounds, and 3-acetyl-7-oxo-dehydroepiandrosterone: each increases the resting metabolic rate of overweight adults

    The Journal of nutritional biochemistry

Latest